![Nerissa Kreher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nerissa Kreher
Direktor/Vorstandsmitglied bei REZOLUTE, INC.
Vermögen: 619 372 $ am 31.05.2024
Aktive Positionen von Nerissa Kreher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REZOLUTE, INC. | Direktor/Vorstandsmitglied | 02.03.2021 | - |
Independent Dir/Board Member | 02.03.2021 | - |
Karriereverlauf von Nerissa Kreher
Ehemalige bekannte Positionen von Nerissa Kreher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENTRADA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 | 01.02.2024 |
Tiburio Therapeutics, Inc.
![]() Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 | 01.10.2020 |
TECTONIC THERAPEUTIC, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.12.2018 | 17.12.2018 |
LARIMAR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2015 | 01.07.2016 |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Nerissa Kreher
The University of North Carolina at Charlotte | Undergraduate Degree |
East Carolina University | Doctorate Degree |
Indiana University | Graduate Degree |
Northeastern University | Masters Business Admin |
The University of North Carolina at Chapel Hill | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 14 |
Operativ
Chief Tech/Sci/R&D Officer | 7 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 9 |
Consumer Services | 6 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
REZOLUTE, INC. | Health Technology |
ENTRADA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Tiburio Therapeutics, Inc.
![]() Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Nerissa Kreher
- Erfahrung